8 studies found for:    NIAID | Open Studies | Exclude Unknown | Hepatitis C
Show Display Options
Rank Status Study
1 Recruiting Combination Therapy for Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Fixed Dose GS-7977/GS-5885;   Drug: GS-7977 + GS-9669
2 Recruiting Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C;   HIV Infections
Intervention:
3 Recruiting Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
4 Recruiting Staged Phase I/II Hepatitis C Prophylactic Vaccine
Condition: Hepatitis C
Interventions: Other: Placebo;   Biological: MVA-NSmut;   Biological: AdCh3NSmut1
5 Recruiting Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN);   Drug: Ribavirin (RBV);   Drug: Boceprevir (BOC)
6 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
7 Recruiting A Phase 2a Study of GS-6624 in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Conditions: Liver Fibrosis;   Hepatitis C;   HIV;   HIV/HCV Co-infection
Intervention: Biological: GS-6624
8 Recruiting Hepatitis C Virus and the Humoral Immune System
Condition: Hepatitis C Virus
Intervention:

Indicates status has not been verified in more than two years